Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TransMedics Group, Inc.TMDX · Entity 4261 | Chief Commercial Officer | March 03, 2025 | March 05, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TransMedics Group, Inc.
Report date March 03, 2025 · Filed March 05, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,042 |
Reported balance
After 2025-03-03 transaction · row 1
1 source rowRow 1 · 2025-03-03 · Sale · Disposed 2,407 · Balance 36,042 F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award. |
Filing footnotes · ownership attribution and instrument terms
F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2023 Filed Mar 2, 2023 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 5,000 | $80.06 | $400,300.00 |
DisclosureSEC source: 0000899243-23-006757 · doc4.xml · nonDerivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By the Khayal Family 2021 Irrevocable Trust Disclosed balance after: 19,776 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.00 to $80.24, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 10,000 | $80.15 | $801,500.00 |
DisclosureSEC source: 0000899243-23-006757 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,375 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.00 to $80.85, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 10,000 | $16.14 | $161,400.00 |
DisclosureSEC source: 0000899243-23-006757 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 20:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,751 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-23-006280 · doc4.xml · derivative · entry 12 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,249 Underlying: Common Stock · 3,751 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F10 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 20:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,179 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-23-006280 · doc4.xml · derivative · entry 11 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,036 Underlying: Common Stock · 32,179 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F9 · derivative.exercise_date: The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 20:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 20,000 | $75.15 | $1,503,000.00 |
DisclosureSEC source: 0000899243-23-006280 · doc4.xml · nonDerivative · entry 8 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,375 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $75.00 to $75.50, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F8 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 20:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 853 | $74.67 | $63,693.51 |
DisclosureSEC source: 0000899243-23-006280 · doc4.xml · nonDerivative · entry 7 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,375 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $74.07 to $74.90, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 20:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 777 | $73.55 | $57,148.35 |
DisclosureSEC source: 0000899243-23-006280 · doc4.xml · nonDerivative · entry 6 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,228 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $73.00 to $73.99, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 20:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 6,218 | $72.02 | $447,820.36 |
DisclosureSEC source: 0000899243-23-006280 · doc4.xml · nonDerivative · entry 5 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,005 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $72.00 to $72.95, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 20:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,763 | $71.46 | $125,983.98 |
DisclosureSEC source: 0000899243-23-006280 · doc4.xml · nonDerivative · entry 4 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,223 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $71.06 to $71.68, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 20:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 6,319 | $70.18 | $443,467.42 |
DisclosureSEC source: 0000899243-23-006280 · doc4.xml · nonDerivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,986 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.92, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 20:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 3,751 | $16.14 | $60,541.14 |
DisclosureSEC source: 0000899243-23-006280 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 20:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 32,179 | $16.00 | $514,864.00 |
DisclosureSEC source: 0000899243-23-006280 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 20:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 20,022 | $0.00 Strike: $66.10 | $0.00 |
DisclosureSEC source: 0000899243-23-005898 · doc4.xml · derivative · entry 4 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,022 Underlying: Common Stock · 20,022 shares Expires 2033-02-20 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 20:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantCommon Stock | 13,075 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005898 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,375 F1 · shares: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 17:15 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,070 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005254 · doc4.xml · derivative · entry 5 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,215 Underlying: Common Stock · 4,070 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 17:15 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 4,070 | $70.15 | $285,510.50 |
DisclosureSEC source: 0000899243-23-005254 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.35, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 17:15 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 4,070 | $16.00 | $65,120.00 |
DisclosureSEC source: 0000899243-23-005254 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 17:36 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,142 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-23-002668 · doc4.xml · derivative · entry 5 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,285 Underlying: Common Stock · 3,142 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 17:36 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 3,142 | $65.07 | $204,449.94 |
DisclosureSEC source: 0000899243-23-002668 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.28, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 17:36 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 3,142 | $16.00 | $50,272.00 |
DisclosureSEC source: 0000899243-23-002668 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 20, 2023 Filed Jan 20, 2023 18:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,558 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-23-002272 · doc4.xml · derivative · entry 8 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,427 Underlying: Common Stock · 5,558 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. Read SEC document |
| January 20, 2023 Filed Jan 20, 2023 18:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 5,558 | $65.21 | $362,437.18 |
DisclosureSEC source: 0000899243-23-002272 · doc4.xml · nonDerivative · entry 4 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.56, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 20, 2023 Filed Jan 20, 2023 18:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 5,558 | $16.00 | $88,928.00 |
DisclosureSEC source: 0000899243-23-002272 · doc4.xml · nonDerivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 18:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,300 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-23-002272 · doc4.xml · derivative · entry 7 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,985 Underlying: Common Stock · 1,300 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 18:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,300 | $65.11 | $84,643.00 |
DisclosureSEC source: 0000899243-23-002272 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.30, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 18:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,300 | $16.00 | $20,800.00 |
DisclosureSEC source: 0000899243-23-002272 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,900 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001859 · doc4.xml · derivative · entry 5 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,285 Underlying: Common Stock · 5,900 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 5,900 | $60.20 | $355,180.00 |
DisclosureSEC source: 0000899243-23-001859 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.73, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 5,900 | $16.00 | $94,400.00 |
DisclosureSEC source: 0000899243-23-001859 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,100 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001013 · doc4.xml · derivative · entry 7 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,185 Underlying: Common Stock · 4,100 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 500 | $62.79 | $31,395.00 |
DisclosureSEC source: 0000899243-23-001013 · doc4.xml · nonDerivative · entry 4 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.52 to $62.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,700 | $61.99 | $167,373.00 |
DisclosureSEC source: 0000899243-23-001013 · doc4.xml · nonDerivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.45 to $62.40, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 900 | $60.93 | $54,837.00 |
DisclosureSEC source: 0000899243-23-001013 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.42 to $61.37, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 4,100 | $16.00 | $65,600.00 |
DisclosureSEC source: 0000899243-23-001013 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 17:29 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 11,051 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-22-037661 · doc4.xml · derivative · entry 4 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,051 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 17:29 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 11,051 | $2.21 | $24,422.71 |
DisclosureSEC source: 0000899243-22-037661 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By the Tamer Ibrahim Ahmed Khayal Trust Disclosed balance after: 11,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,254 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-22-036016 · doc4.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,051 Underlying: Common Stock · 4,254 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 4,254 | $60.06 | $255,495.24 |
DisclosureSEC source: 0000899243-22-036016 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.19, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 4,254 | $2.21 | $9,401.34 |
DisclosureSEC source: 0000899243-22-036016 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:25 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,702 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-22-035758 · doc4.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,305 Underlying: Common Stock · 2,702 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:25 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,702 | $60.03 | $162,201.06 |
DisclosureSEC source: 0000899243-22-035758 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.27, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:25 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 2,702 | $2.21 | $5,971.42 |
DisclosureSEC source: 0000899243-22-035758 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 17:16 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,044 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-22-035453 · doc4.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,007 Underlying: Common Stock · 3,044 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 17:16 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 3,044 | $60.04 | $182,761.76 |
DisclosureSEC source: 0000899243-22-035453 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.36, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 17:16 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 3,044 | $2.21 | $6,727.24 |
DisclosureSEC source: 0000899243-22-035453 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 24, 2022 Filed Aug 25, 2022 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,976 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-22-029753 · doc4.xml · derivative · entry 8 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,051 Underlying: Common Stock · 1,976 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 24, 2022 Filed Aug 25, 2022 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,976 | $50.22 | $99,234.72 |
DisclosureSEC source: 0000899243-22-029753 · doc4.xml · nonDerivative · entry 6 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $50.00 to $50.72, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 24, 2022 Filed Aug 25, 2022 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,976 | $2.21 | $4,366.96 |
DisclosureSEC source: 0000899243-22-029753 · doc4.xml · nonDerivative · entry 5 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 24, 2022 Filed Aug 25, 2022 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,514 | $50.18 | $126,152.52 |
DisclosureSEC source: 0000899243-22-029753 · doc4.xml · nonDerivative · entry 4 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By the Khayal Family 2021 Irrevocable Trust Disclosed balance after: 24,776 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $50.00 to $50.72, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.